Bluejay Diagnostics Q4 EPS $(1.78) Misses $(0.68) Estimate
Portfolio Pulse from Benzinga Newsdesk
Bluejay Diagnostics (NASDAQ:BJDX) reported a Q4 EPS loss of $(1.78), missing the consensus estimate of $(0.68) by 161.76%. This represents a 25.83% improvement over the $(2.40) per share loss from the same period last year.

March 29, 2024 | 4:56 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Bluejay Diagnostics reported a larger than expected Q4 loss per share of $(1.78), missing the $(0.68) estimate, but improved from last year's $(2.40) loss.
The significant miss in earnings expectations typically leads to negative investor sentiment in the short term, hence the negative score. The improvement over the previous year's loss indicates some progress, but the miss on analyst expectations is likely to have a more immediate impact on the stock price.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100